(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PDNAHERO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PDNAHERO

ST13

US500000098054252

Class

1, 5

Filing

98054252

Registration

7896001

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

08/19/2025

Trademark type

Word

Nice classes

1, 5

Filing date

06/22/2023

Registration date

08/19/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/19/2025

Last transaction

08/19/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

4

Owner type

99

Owner location

Comberton, Cambridge, GB

Examiner

HAN, DAWN L

Law office

L70

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

ASTREA UK SERVICES LIMITED

Representatives

BEN NATTER HAUG PARTNERS, LLP

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Polymeric nanofiber filtering compositionsadsorptive filters for chromatographic separationsfor purification and separation of nucleic acids other than for medical and veterinary purposes; polymeric nanofiber filtering materialsadsorptive filters for chromatographic separationsfor purification and separation of nucleic acids other than for medical and veterinary purposes; filtering materials in the nature of unprocessed plasticsceramic particlesfor purification and separation of nucleic acids from chemical and biological substancesother than for medical and veterinary purposes; chromatographic media for purification of nucleic acidsother than for medical and veterinary purposes; filtering media consisting of chemicals and biological preparations for purification and separation of nucleic acidsother than for medical and veterinary purposes; chemical and biological absorbents and adsorbents for recovery of nucleic acidsother than for medical and veterinary purposes; chemical and biological purifying agents for purification and separation of nucleic acids from chemical and biological preparationsother than for medical and veterinary purposes; chemical and biological preparations for use in bioseparation for purification and separation of nucleic acidsother than for medical and veterinary purposes; chemical and biological preparations for use in filtering for purification and separation of nucleic acidsother than for medical and veterinary purposes; chemical and biological adsorptive filters for chromatographic separationfor use in separation for purification and separation of nucleic acidsother than for medical and veterinary purposes; fibres of inorganic polymeric materialsilica or glass fibres for the separation of nucleic acids from other nucleic acids or other biological compoundsfor separation purposes for purification and separation of nucleic acidsother than for medical and veterinary purposes; fibres of organic polymeric materialcellulosic fibres or composite cellulosic fibres for the separation of nucleic acids from other nucleic acids or other biological compoundsfor separation purposes for purification and separation of nucleic acidsother than for medical and veterinary purposes; chemical reagents in the form of nucleic acids for scientific and medical purposes; protein in raw material form for scientific and medical research; protein in raw material form for scientific and industrial use; enzymes for scientific and industrial use; chemical reagents for scientific and research use other than for medical use; chemical preparations for use in industryligands for scientific and research use; biochemicalsantibodies and antibody fragments in the nature of antibodiesall for in vitro scientific or research use

Class 5

Proteins in raw material form and protein arraysall for medical diagnostic purposes; enzymes for medical use; chemical reagents in the form of nucleic acids for medical use; proteinschemical reagents in the form of polypeptides for medical use; medical diagnostic reagents and clinical medical reagents; insulin; insulin analogues consisting primarily and insulin; polymeric nanofiber filtering compositionsadsorptive filters for chromatographic separationsfor purification and separation of nucleic acids for medical and veterinary purposes; polymeric nanofiber filtering materialsadsorptive filters for chromatographic separationsfor purification and separation of nucleic acids for medical and veterinary purposes; filtering materials in the nature of unprocessed plasticsceramic particlesfor purification and separation of nucleic acids from chemical and biological substancesfor medical and veterinary purposes; filtering media consisting of chemicals and biologicals for purification and separation of nucleic acids comprising of chemicals and biologicalsfor medical and veterinary purposes; chemical and biological absorbents and adsorbents for recovery of nucleic acidsfor medical and veterinary purposes; chemical and biological preparations featuring the purification and separation of nucleic acids from chemical and biological preparationsfor medical and veterinary purposes; chemical and biological preparations for use in bioseparation for purification and separation of nucleic acidsfor medical and veterinary purposes; chemical and biological preparations for use in filtering for purification and separation of nucleic acidsfor medical and veterinary purposes; chemical and biological preparations for use in separation for purification and separation of nucleic acidsfor medical and veterinary purposes; fibres of inorganic polymeric materialsilica or glass fibres for the separation of nucleic acids from other nucleic acids or other biological compoundsfor separation purposes for purification and separation of nucleic acidsfor medical and veterinary purposes; fibres of organic polymeric materialadsorptive filters for chromatographic separationfor the separation of nucleic acids or other biological compoundsfor separation purposes for purification and separation ofnucleic acidsfor medical and veterinary purposes

Publications

History of USPTO decisions and trademark events.

35 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/19/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

08/19/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/03/2025

PUBO

PUBLISHED FOR OPPOSITION

06/03/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/28/2025

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

05/09/2025

EXPT

EXPARTE APPEAL TERMINATED

04/24/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/24/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

04/24/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

04/24/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

04/24/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

04/24/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/13/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/13/2025

ALIE

ASSIGNED TO LIE

02/13/2025

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

02/10/2025

EXPI

EX PARTE APPEAL-INSTITUTED

02/10/2025

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

02/10/2025

EXAF

EXPARTE APPEAL RECEIVED AT TTAB

02/10/2025

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

11/07/2024

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

11/07/2024

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

08/14/2024

GNFR

FINAL REFUSAL E-MAILED

08/14/2024

CNFR

FINAL REFUSAL WRITTEN

08/14/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/10/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/10/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/10/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/11/2024

GNRT

NON-FINAL ACTION E-MAILED

04/11/2024

CNRT

NON-FINAL ACTION WRITTEN

04/11/2024

DOCK

ASSIGNED TO EXAMINER

03/11/2024

TAEA

TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED

01/24/2024

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

01/24/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/25/2023

NWAP

NEW APPLICATION ENTERED

06/26/2023

Continuous trademark protection

Get notified about every new filing that threatens PDNAHERO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.